Article Details

Analysts See $-1.04 EPS for Theravance Biopharma, Inc. (TBPH)

Retrieved on: 2019-10-03 12:07:30

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $-1.04 EPS for Theravance Biopharma, Inc. (TBPH). View article details on hiswai:

Excerpt

<div><b>Baupost Group</b> Limited Liability Corporation Ma owns 9.31M shares for 1.38% of their portfolio. Goldman Sachs, New York-based fund reported ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up